Private Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Private Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-11,100	Closed	-$210K	–	137
2017 Q4	$210K	Sell	11,100 -21,375	-66%	-$322K	0.03%	133
2017 Q3	$572K	Sell	32,475 -144,545	-82%	-$3.25M	0.09%	94
2017 Q2	$5.88M	Buy	177,020 +53,945	+44%	+$1.67M	0.95%	40
2017 Q1	$3.95M	Buy	123,075 +9,727	+9%	+$332K	0.64%	46
2016 Q4	$4.11M	Buy	113,348 +2,090	+2%	+$83.4K	0.69%	46
2016 Q3	$5.12M	Buy	111,258 +670	+0.6%	+$35K	0.86%	39
2016 Q2	$5.55M	Buy	110,588 +40,850	+59%	+$2.17M	0.98%	37
2016 Q1	$3.73M	Sell	69,738 -4,050	-5%	-$238K	0.68%	47
2015 Q4	$4.84M	Sell	73,788 -5,425	-7%	-$335K	0.88%	38
2015 Q3	$4.47M	Sell	79,213 -61,045	-44%	-$3.96M	0.84%	38
2015 Q2	$8.29M	Sell	140,258 -31,300	-18%	-$1.93M	1.39%	24
2015 Q1	$10.7M	Sell	171,558 -4,585	-3%	-$267K	1.74%	19
2014 Q4	$10.1M	Sell	176,143 -3,719	-2%	-$207K	1.61%	22
2014 Q3	$9.67M	Sell	179,862 -1,452	-0.8%	-$76.9K	1.55%	21
2014 Q2	$9.5M	Sell	181,314 -11,448	-6%	-$585K	1.53%	21
2014 Q1	$10.2M	Sell	192,762 -395	-0.2%	-$18.3K	1.72%	16
2013 Q4	$7.74M	Buy	193,157 +15,895	+9%	+$626K	1.33%	25
2013 Q3	$6.7M	Sell	177,262 -40,767	-19%	-$1.59M	1.28%	26
2013 Q2	$8.55M	Buy	+218,029	New	+$8.49M	1.63%	17

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Private Asset Management's TEVA Position: Q1 2018 in Review

Private Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q1 2018, closing a stake of 11,100 shares — an estimated $210K sold.

Private Asset Management first reported a position in TEVA in Q2 2013 and held it in 19 quarters. The position peaked at $10.7M in Q1 2015. 506 funds tracked by Wall St. Rank hold TEVA as of Q1 2018.

Private Asset Management reported no remaining Teva Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
Private Asset Management sold 11,100 Teva Pharmaceuticals shares in Q1 2018, an estimated $210K.
Private Asset Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 19 quarters.
Private Asset Management's Teva Pharmaceuticals position peaked at $10.7M in Q1 2015.
506 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2018.

Based on Private Asset Management's 13F filing for Q1 2018, filed 6 Apr 2018.